Patients denied arthritis drug19th January 2010
An arthritis drug has been approved for people in Scotland, although the National Institute for Health and Clinical Excellence said it was too expensive for patients in England and Wales.
The drug, Toclizumab, can significantly reduce symptoms. Leading rheumatologist Professor John Isaacs, from the Institute of Cellular Medicine at the University of Newcastle, said: "This is fantastic news for people in Scotland who suffer from this disabling, life-long disease. However, it also highlights the disparities in accessing treatment between Scotland and the rest of the UK."
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Patients denied arthritis drug
Author: Jess Laurence
Article Id: 13813
Date Added: 19th Jan 2010